Sensorineural Hearing Loss Clinical Trial
Official title:
Correlation of Auditory Evoked Brainstem Response Characteristics and Salivary Cortisone Concentration in Noise-exposed Workers
The aim of the research:
Investigate the association of auditory evoked brainstem response characteristics with
salivary cortisone concentrations in noise-exposed workers.
Purpose of the research:
1. Investigate the magnitude of the amplitudes and latencies of auditory brainstem
responses.
2. Investigate the concentration of cortisone in saliva.
3. To investigate the correlation of the characteristics of auditory evoked brainstem
potentials with the age of the subjects or the length of work in noise.
4. Investigate the association of salivary cortisone concentration with subjects' age or
length of work in noise.
5. Investigate the prevalence of mild, moderate and severe hearing impairment in the 19-35
age group.
6. Investigate the relationship of hearing threshold shift with the age of the subjects or
the length of work in noise.
7. To investigate the difference in the characteristics of auditory evoked brainstem
potentials and the difference in salivary cortisone concentration between subjects with
a bilaterally normal hearing threshold (≤25 dB) at high frequencies and subjects with
unilaterally or bilaterally increased hearing threshold (> 25 dB) at high frequencies .
8. Investigate the perceived stress and psychosocial risk factors in the workplace and
their relationship to salivary cortisone concentrations.
Research Hypothesis:
There is an association between the characteristics of auditory evoked brainstem response and
salivary cortisone concentrations in noise-exposed workers.
Research participants
Inclusion criteria:
1. male and female
2. ages 19-35
3. exposure to noise level ≥ 85 dB (A) per week at the workplace
4. work in noise from 1 to 16 years
5. workplace not involving exposure to carbon disulfide or a mixture of organic solvents
that have toxic effects on the ear (toluene, xylene and styrene)
6. unilaterally or bilaterally normal otoscopic findings
7. unilaterally or bilaterally tympanogram: peak pressure value ± 50 daPa at 226 Hz with
eardrum mobility of 0.3 to 1.3 mL
Exclusion criteria:
1. information about an earlier sudden hearing loss
2. information on chronic middle ear inflammation
3. information on ear surgery (except placement of ventilation tubes in the eardrum)
4. information on dizziness associated with hearing loss and noise
5. information on insomnia
6. current use of oral corticosteroids
7. bilaterally found air-bone gap greater than 15 dB
The research is cross-sectional. The expected duration of the survey is at least 18 months.
Assuming that the characteristics of the auditory evoked brainstem potentials are correlated
with salivary cortisone concentration with a correlation coefficient of 0.4, a test power of
80% and a significance level of α = 0.05, at least 46 subjects should be included in the
study. Test power analysis was performed using MedCalc Statistical Software, version 19.1
(MedCalc Software bv, Ostend, Belgium; https://www.medcalc.org; 2019). According to the data
distribution (Kolmogorov-Smirnov test), appropriate parametric and / or non-parametric
statistical tests will be applied in accordance with the obtained results. The data will be
presented in tables and graphs. Numerical variables will be represented using the range,
arithmetic mean and standard deviation, respectively, the median and the interquartile range,
in cases of distribution that does not follow the normal distribution. The categorical
variables will be presented using absolute frequencies and their respective proportions.
Differences in the values of the numerical variables between the test groups with a defined
hearing threshold will be analyzed by parametric Student's t-test for independent samples,
and non-parametric Mann-Whitney U test for independent samples. Differences in categorical
variables between the examined groups will be analyzed by chi-square test or Fisher's exact
test in cases where the number of subjects in each group is less than 5. The corresponding
correlation coefficients (Pearson's or Spearman's) between individual clinical variables will
be calculated. An appropriate regression model for the prediction of belonging to a group
with a defined hearing threshold shift will be made, which will include those that have a
significance level of P≤0.20 in the previous statistical analyzes. In the above tests,
significant P values will be considered to be less than 0.05. The statistical analysis of
data will use IBM SPSS Statistics licensed software version 25.0.
Material:
1. Audiometer Audiometer AC40
2. DD45 audiometric headphones
3. Interacoustics AZ26 tympanometer
4. Equipment for testing auditory evoked brainstem potentials: ABR Interacoustics Eclipse,
EPA Preamplifier, 3M E-A-RTONE Insert Earphone ABR
5. Cortisol-Salivette Cotton Salad Carrier
6. High Performance Liquid Chromatography (HPLC)
7. validated questionnaire in the Croatian language - assessment of psychosocial risk
factors in the HSE workplace 8th validated questionnaire in Croatian - The scale of
stress experienced
Research plan:
An employer finds workers who meet points 1-5 of study inclusion criteria. A head of the
research checks their medical history and includes them in the study if they do not meet any
of first six exclusion criteria. A head of the research orally informs these workers at the
meeting and helps them to understand and sign a written informed consent for participation in
the research. Each of them receive an information about the date of arrival at the place of
research and also a unique password that encodes saliva samples, completed questionnaires and
electronic and printed findings derived from the assessment of hearing health. The research
leader, research mentors, and occupational safety manager, who is responsible for supervising
the sampling and storage of saliva samples in the refrigerator at +4 ℃ in the workplace, know
the password and associated name.
A participant is expected to:
1. Give three saliva samples at the workplace immediately after the morning shift. The
first saliva sample was given 3 days (Tuesday) before arrival at the research place, the
second sample 2 days (Wednesday) before arrival, and the third sample 1 day (Thursday)
before arrival at the research site. One hour before saliva sampling, a respondent
should not brush his/her teeth nor eat nor drink. Fifteen minutes prior to sample
administration, the subject should rinse his/her mouth with a cold water. Then head of
the research analyses coded saliva samples in laboratory by using High Performance
Liquid Chromatography (HPLC) at the Translational Medicine Division of the Srebrnjak
Children's Hospital. After processing and preparing each of the saliva samples for HPLC,
the native sample no longer exists. After the analytes will be detected in the isolate,
all the material will be completely eliminated as infectious waste.
2. Collaboration in the process of assessing hearing health at the research place. The
assessment includes: otoscopy, tympanometry and audiometry. Subjects who do not meet
point 6 and 7 of the inclusion criteria or who meet point 7 of the exclusion criteria
will not be tested for auditory evoked brainstem response. Other subjects will be tested
for auditory evoked brainstem response in only one ear, with a more regular hearing
threshold.
3. Self-assessment of perceived stress and psychosocial risk factors in the workplace by
completing a questionnaire at the research site.
A researcher conducting this research and the research participants will not receive a
financial fee for their participation.
Expected scientific contribution of the research:
Quantification of the association of auditory evoked brainstem response characteristics with
salivary cortisone concentrations among workers exposed to noise.
Possible risks of participating in the research:
This research involves no risk other than the usual daily risk.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00023036 -
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
|
||
Completed |
NCT03746613 -
Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques
|
N/A | |
Recruiting |
NCT05568329 -
Appreciation for Music Processed by Hearing Aids
|
N/A | |
Withdrawn |
NCT05061758 -
A Trial of LY3056480 in Patients With SNLH
|
Phase 2 | |
Completed |
NCT01434446 -
The Effect of Sound Stimulation on Hearing Ability
|
N/A | |
Completed |
NCT03212924 -
Listening Effort in Cochlear Implant Users
|
N/A | |
Recruiting |
NCT06053190 -
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
|
N/A | |
Completed |
NCT03718975 -
Quality Control of CE-Certified Phonak Hearing Aids - 2018_28
|
N/A | |
Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 | |
Recruiting |
NCT04102215 -
The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure
|
N/A | |
Recruiting |
NCT04108598 -
The SeaSHeL National Prospective Cohort Study
|
||
Active, not recruiting |
NCT04750642 -
Cochlear Implant With Dexamethasone Eluting Electrode Array
|
N/A | |
Completed |
NCT04120116 -
FX-322 in Adults With Stable Sensorineural Hearing Loss
|
Phase 2 | |
Recruiting |
NCT06223724 -
Status Telemetry for Cochlear Implantations
|
||
Completed |
NCT02005822 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
|
Phase 3 | |
Suspended |
NCT02616172 -
Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
|
Phase 1/Phase 2 | |
Completed |
NCT02259595 -
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
|
Phase 1 | |
Unknown status |
NCT01902914 -
Effectiveness of P02 Digital Hearing Aids
|
Phase 1/Phase 2 | |
Completed |
NCT00589511 -
Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study
|
N/A | |
Completed |
NCT03288753 -
Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors
|
N/A |